Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC : revenue, balance sheet and financial ratios

S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC is a French company founded 35 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LAGNY-SUR-MARNE (77400), this company of category PME shows in 2023 a revenue of 3.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC (SIREN 380846188)
Indicador 2024 2023 2022 2021 2020 2019 2018 2017 2016
Ingresos N/C 3 027 557 € N/C N/C N/C N/C N/C N/C N/C
Resultado neto 55 064 € -19 360 € 3 704 € 21 324 € -13 581 € -23 500 € 80 792 € 73 516 € 97 326 €
EBITDA N/C -36 741 € N/C N/C N/C N/C N/C N/C N/C
Margen neto N/C -0.6% N/C N/C N/C N/C N/C N/C N/C

Ingresos y cuenta de resultados

In 2024, S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC generates positive net income of 55 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 97 k€ -> 55 k€.

Resultado neto (2024) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

55 064 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Ratio de endeudamiento (2024) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

2.08%

Autonomía financiera (2024) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

73.526%

Ratio de obsolescencia (2024) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

18.1%

Evolución de indicadores de solvencia
S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC

Positionnement sectoriel

Debt ratio
2.08 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of S.E.A.R.L. DE PHARMACIEN ... (2.08) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
73.53% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Excellent

In 2024, the financial autonomy of S.E.A.R.L. DE PHARMACIEN ... (73.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
-0.49 years 2023
2023
Q1: 0.95 years
Méd: 3.59 years
Q3: 7.48 years
Excellent

In 2023, the repayment capacity of S.E.A.R.L. DE PHARMACIEN ... (-0.49) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 122.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2024) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

122.01

Evolución de indicadores de liquidez
S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC

Positionnement sectoriel

Liquidity ratio
122.01 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Watch

In 2024, the liquidity ratio of S.E.A.R.L. DE PHARMACIEN ... (122.01) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
0.0x 2023
2023
Q1: 0.38x
Méd: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of S.E.A.R.L. DE PHARMACIEN ... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Necesidad de fondo de rotación (NFR) y plazos de pago

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

NFR de explotación (2024) ?
NFR de explotación
Definición
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Fórmula
Stocks + Créances clients - Dettes fournisseurs
Interpretación
Negativo = tesorería liberada
Positivo = necesidad de financiación

0 €

Crédito clientes (2024) ?
Crédito clientes (días)
Definición
Plazo medio de cobro a clientes.
Fórmula
(Cuentas por cobrar / Ingresos con IVA) x 360
Interpretación
< 45j : Bueno
45-60j : Medio
> 60j : Largo

0 j

Crédito proveedores (2024) ?
Crédito proveedores (días)
Definición
Plazo medio de pago a proveedores.
Fórmula
(Cuentas por pagar / Compras con IVA) x 360
Interpretación
Cuanto más largo sea el plazo, mejor para la tesorería

0 j

Rotación de inventario (2024) ?
Rotación de inventario (días)
Definición
Duración media de almacenamiento de mercancías o materiales.
Fórmula
(Existencias / Coste de compra) x 360
Interpretación
Cuanto menor sea el ratio, más rápida es la rotación

0 j

Evolución del NFR y plazos
S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC

Positionnement de S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 225 transactions of similar company sales in 2024, the value of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC is estimated at 768 734 € (range 535 334€ - 1 150 070€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
535k€ 768k€ 1150k€
768 734 € Range: 535 334€ - 1 150 070€
NAF 5 année 2024

Valuation method used

Net Income Multiple
55 064 € × 14.0x = 768 734 €
Range: 535 334€ - 1 150 070€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC

What is the revenue of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC ?

The revenue of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC in 2023 is 3.0 M€.

Is S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC profitable?

Yes, S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC generated a net profit of 55 k€ in 2024.

Where is the headquarters of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC ?

The headquarters of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC is located in LAGNY-SUR-MARNE (77400), in the department Seine-et-Marne.

Where to find the tax return of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC ?

The tax return of S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC operate?

S.E.A.R.L. DE PHARMACIEN D'OFFICINE- PHARMACIE ORLY PARC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.